mommyjenlin

How much more effective would your marketing campaigns in traditional, online, social, mobile and Public/Media relations be, if you made a conscious effort to frame your messaging in your communications campaigns around the main brand and key messages you use in your marketing campaigns? More often than not, brand messages in healthcare communications sometimes lack the level of integration and planning needed across vehicles and channels. Little, if any attention, is given to using communications as a strategic and integrative vehicle in the overall marketing effort. With so many different marketing activities and channels required to cut through the clutter, in order to leverage your key messages, you can no longer afford to not have your communications highly integrated with marketing. Is that lack of integration a missed opportunity? We are expected by our audiences to advertise, write white papers, create case studies, write impactful sales materials, partner with leading market r

Between May 15th and July 31st, 2011, IDC's CMO Advisory Group fielded its 9th annual Tech Marketing Benchmarks Study. More than 100 tech companies representing about $850B in revenue responded, making this the CMO Advisory Group's most successful benchmarking study to date. The average revenue for companies in this data set is $9.5B, and these data include companies ranging from less than $500M to about $100B. Technology hardware, software, and services companies with both direct and indirect channel strategies are represented in the database. The following are some key findings from IDC's 2011 Tech Marketing Benchmarks Study. Marketing investment growth in 2011 is lagging revenue growth at 3.5% and 6.5% respectively. Moreover, the 3.5% marketing investment change figure is significantly lower than tech marketer's sentiments in January of 2011, when they reported expectations of an 8% increase to marketing budgets. In past years, IDC's CMO Advisory Group has

Tough economy and getting worse. Hospital volume, scripts and specialty drug orders, flat or down. Little differentiation among competitors in many healthcare verticals. New proposed cuts in Medicare and Medicaid spending. High unemployment with no end in sight. Political gridlock. Healthcare payment models evolving from production payment focused on care delivered, to pay-for-performance based on quality outcomes. Price competition. And finally, a growing empowered healthcare consumer, taking control and playing an active part in the healthcare decision-making process. With all this transpiring, most are taking the same past course of marketing action. Advertise services by making claims of world-class service. "Me too" messaging, attempting to driving volume because we focus all of our efforts and resources around you. (Isn't that what you are supposed to do anyway?) Sales forces all focusing on the same a therapy or drug class in specialty pharmacy which, in most cases

The old two-step marketing and sales model for customer creation is dead. Today we have a three part model: Socializing, Marketing, and Sales – with socializing taking on increasing importance and marketing being redefined in the process. That’s a good thing for customers but it makes the market more competitive for sellers. Companies have to seek out and engage with both existing and potential customers in radically new ways outside of explicit business contexts with resources previously not thought of as customer facing. This activity is going on today at a furious pace, but it is highly fragmented. With the introduction by Salesforce.com of Data.com and the social ready rebuild of Database.com at Dreamforce, as well their Chatter and CRM capabilities, customer interactions will come together in what is emerging as the Customer Cloud – the first killer app for the social enterprise. The Customer Cloud will evolve into the source of record for all account and contact data because it c

When you consider all the time, resources and effort spent, in developing patient educational materials, by specialty pharmacies along the therapies of RA, MS, HIV/AIDS, Oncology and Transplant, payers, PBMs, pharmaceutical manufactures, disease-specific associations and hospitals, one would surmise that an opportunity exists, to use them in broader channel marketing efforts. Pharma and disease-specific associations have great and innovative marketing programs around patient education. After that, specialty pharmacy's, PBMs, and hospitals, not so much. I think that their use in marketing campaigns will depend greatly on the quality of the materials. And in some cases, they are pretty poorly written and designed. Sometimes lacking all together. But are all healthcare segments, especially specialty pharmacies, missing an opportunity to truly differentiate themselves in a lookalike marketplace? I know. We all think we are the best at what we do, offering considerable expertise, advice

This is not about guerilla marketing. I am writing about engaging in what I call Disruptive Healthcare Marketing (DHM). DHM is a process that moves you from looking like a "me too" in your healthcare marketing, to forcing competitors into changing their game, reacting to you. If for the sake of argument, you can agree that there is little meaningful differentiation , healthcare is becoming a commodity , price competition is beginning, and the healthcare consumer is becoming more empowered and taking control, then why would you continue to market the same old ways and play follow the leader in your industry vertical? Isn't that the definition of insanity? Doing the same thing over and over again and expecting a different result. Disruption is occurring across healthcare on a daily basis and well into the foreseeable future. So why isn't healthcare marketing keeping pace? Much healthcare marketing is like Lemmings in a herd, falling over the cliff because everybody e